首页> 外文期刊>Stem cells translational medicine. >Epidermal Growth Factor Tethered to beta-Tricalcium Phosphate Bone Scaffolds via a High-Affinity Binding Peptide Enhances Survival of Human Mesenchymal Stem Cells/Multipotent Stromal Cells in an Immune-Competent Parafascial Implantation Assay in Mice
【24h】

Epidermal Growth Factor Tethered to beta-Tricalcium Phosphate Bone Scaffolds via a High-Affinity Binding Peptide Enhances Survival of Human Mesenchymal Stem Cells/Multipotent Stromal Cells in an Immune-Competent Parafascial Implantation Assay in Mice

机译:通过高亲和力结合肽拴在β-磷酸三钙骨支架上的表皮生长因子提高了人间充质干细胞/多能基质细胞在小鼠中具有免疫功能的筋膜植入试验中的存活率

获取原文
获取原文并翻译 | 示例
           

摘要

Mesenchymal stem cells/multipotent stromal cells (MSCs) are attractive candidates for cell therapies owing to their ability to differentiate into many lineages. However, these cells often fail to survive when implanted into a harsh wound environment, limiting efficacy in vivo. To improve MSC survival, we previously found that tethered epidermal growth factor (tEGF) molecules that restrict epidermal growth factor receptor (EGFR) signaling to the cell surface provide resistance to death signals. To adapt this system to wound healing, we tethered epidermal growth factor (EGF) to tricalcium phosphate (TCP) particle scaffolds, clinically used in bone healing. Human primary MSCs seeded on TCP and mixed into a collagen-based gel were injected in the perifascial space of immunocompetent mice with or without tEGF attached to the surface. We found that tethering EGF to the TCP scaffolds yielded approximately a fourfold increase in MSC survival compared with non-EGF scaffolds at 21 days, as well as significant improvements in survival in the short term at 2 and 7 days after implantation. Overall, our approach to sustaining EGFR signaling reduced MSC death in vivo and may be useful for future cell therapies where MSCs typically die on implantation.
机译:间充质干细胞/多能基质细胞(MSCs)由于具有分化成许多谱系的能力而成为细胞疗法的诱人候选物。然而,这些细胞在植入严酷的伤口环境中时通常无法存活,从而限制了体内功效。为了提高MSC的生存率,我们以前发现限制表皮生长因子受体(EGFR)信号传递到细胞表面的拴系表皮生长因子(tEGF)分子对死亡信号具有抵抗力。为了使该系统适应伤口愈合,我们将表皮生长因子(EGF)拴在临床上用于骨骼愈合的磷酸三钙(TCP)颗粒支架上。将接种在TCP上并混入胶原蛋白凝胶中的人原代MSC注入免疫活性小鼠的筋膜腔中,无论其表面是否附着tEGF。我们发现,与非EGF支架相比,将EGF拴在TCP支架上的MSC生存时间比非EGF支架在21天时增加了大约四倍,并且在植入后2天和7天的短期内生存率有了显着提高。总体而言,我们维持EGFR信号转导的方法减少了MSC在体内的死亡,对于将来通常在植入MSC时死亡的细胞疗法可能有用。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号